vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与SECURITY NATIONAL FINANCIAL CORP（SNFCA）财务数据对比。点击上方公司名可切换其他公司
SECURITY NATIONAL FINANCIAL CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$83.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 4.7%），SECURITY NATIONAL FINANCIAL CORP自由现金流更多（$43.8M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.1%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CNO金融集团（原康塞科公司）是一家总部位于美国印第安纳州卡梅尔的金融服务控股公司。旗下保险子公司面向美国超过四百万客户提供人寿保险、年金以及补充健康保险产品，产品销售渠道包括独立代理人、专职代理人，以及通过电视广告和直邮直接触达客户。
PBYI vs SNFCA — 直观对比
营收规模更大
SNFCA
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出23.0%
4.7%
自由现金流更多
SNFCA
多$29.5M
$14.4M
两年增速更快
PBYI
近两年复合增速
1.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $83.0M |
| 净利润 | — | $13.5M |
| 毛利率 | 69.3% | 98.6% |
| 营业利润率 | 22.7% | 20.9% |
| 净利率 | — | 16.3% |
| 营收同比 | 27.7% | 4.7% |
| 净利润同比 | — | 430.9% |
| 每股收益（稀释后） | $0.26 | $0.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISNFCA
| Q4 25 | $75.5M | $83.0M | ||
| Q3 25 | $54.5M | $89.3M | ||
| Q2 25 | $52.4M | $89.5M | ||
| Q1 25 | $46.0M | $82.7M | ||
| Q4 24 | $59.1M | $79.3M | ||
| Q3 24 | $80.5M | $88.3M | ||
| Q2 24 | $47.1M | $85.8M | ||
| Q1 24 | $43.8M | $81.2M |
净利润PBYISNFCA
| Q4 25 | — | $13.5M | ||
| Q3 25 | $8.8M | $7.8M | ||
| Q2 25 | $5.9M | $6.5M | ||
| Q1 25 | $3.0M | $4.3M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $20.3M | $11.8M | ||
| Q2 24 | $-4.5M | $7.3M | ||
| Q1 24 | $-4.8M | $7.5M |
毛利率PBYISNFCA
| Q4 25 | 69.3% | 98.6% | ||
| Q3 25 | 77.7% | 98.8% | ||
| Q2 25 | 76.5% | 98.7% | ||
| Q1 25 | 77.1% | 98.5% | ||
| Q4 24 | 76.4% | 98.5% | ||
| Q3 24 | 63.9% | 98.7% | ||
| Q2 24 | 77.4% | 98.6% | ||
| Q1 24 | 75.5% | 98.4% |
营业利润率PBYISNFCA
| Q4 25 | 22.7% | 20.9% | ||
| Q3 25 | 17.6% | 11.4% | ||
| Q2 25 | 12.7% | 9.3% | ||
| Q1 25 | 8.7% | 6.7% | ||
| Q4 24 | 22.6% | 4.0% | ||
| Q3 24 | 27.4% | 17.2% | ||
| Q2 24 | -4.6% | 10.9% | ||
| Q1 24 | -5.3% | 11.8% |
净利率PBYISNFCA
| Q4 25 | — | 16.3% | ||
| Q3 25 | 16.2% | 8.7% | ||
| Q2 25 | 11.2% | 7.3% | ||
| Q1 25 | 6.5% | 5.2% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 25.2% | 13.4% | ||
| Q2 24 | -9.6% | 8.5% | ||
| Q1 24 | -11.0% | 9.2% |
每股收益（稀释后）PBYISNFCA
| Q4 25 | $0.26 | $0.52 | ||
| Q3 25 | $0.17 | $0.31 | ||
| Q2 25 | $0.12 | $0.25 | ||
| Q1 25 | $0.06 | $0.18 | ||
| Q4 24 | $0.40 | $0.09 | ||
| Q3 24 | $0.41 | $0.47 | ||
| Q2 24 | $-0.09 | $0.29 | ||
| Q1 24 | $-0.10 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $102.3M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $410.4M |
| 总资产 | $216.3M | $1.6B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYISNFCA
| Q4 25 | $97.5M | $102.3M | ||
| Q3 25 | $94.4M | $100.4M | ||
| Q2 25 | $96.0M | $79.3M | ||
| Q1 25 | $93.2M | $132.9M | ||
| Q4 24 | $101.0M | $140.5M | ||
| Q3 24 | $96.7M | $170.7M | ||
| Q2 24 | $96.8M | $143.6M | ||
| Q1 24 | $107.2M | $150.9M |
总债务PBYISNFCA
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYISNFCA
| Q4 25 | $130.3M | $410.4M | ||
| Q3 25 | $115.3M | $365.4M | ||
| Q2 25 | $104.7M | $354.8M | ||
| Q1 25 | $97.1M | $346.5M | ||
| Q4 24 | $92.1M | $381.9M | ||
| Q3 24 | $71.1M | $346.3M | ||
| Q2 24 | $48.5M | $325.8M | ||
| Q1 24 | $51.0M | $320.1M |
总资产PBYISNFCA
| Q4 25 | $216.3M | $1.6B | ||
| Q3 25 | $202.9M | $1.6B | ||
| Q2 25 | $194.9M | $1.5B | ||
| Q1 25 | $196.2M | $1.5B | ||
| Q4 24 | $213.3M | $1.5B | ||
| Q3 24 | $220.7M | $1.5B | ||
| Q2 24 | $205.0M | $1.5B | ||
| Q1 24 | $214.1M | $1.4B |
负债/权益比PBYISNFCA
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $45.5M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $43.8M |
| 自由现金流率自由现金流/营收 | 19.1% | 52.8% |
| 资本支出强度资本支出/营收 | 0.0% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 3.38× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $69.8M |
8季度趋势，按日历期对齐
经营现金流PBYISNFCA
| Q4 25 | $14.4M | $45.5M | ||
| Q3 25 | $9.7M | $25.6M | ||
| Q2 25 | $14.1M | $-7.7M | ||
| Q1 25 | $3.6M | $9.6M | ||
| Q4 24 | $15.6M | $57.3M | ||
| Q3 24 | $11.0M | $26.8M | ||
| Q2 24 | $1.0M | $-17.0M | ||
| Q1 24 | $11.2M | $25.1M |
自由现金流PBYISNFCA
| Q4 25 | $14.4M | $43.8M | ||
| Q3 25 | $9.7M | $24.9M | ||
| Q2 25 | $14.1M | $-8.1M | ||
| Q1 25 | $3.6M | $9.1M | ||
| Q4 24 | $15.6M | $54.8M | ||
| Q3 24 | $11.0M | $26.6M | ||
| Q2 24 | $1.0M | $-17.1M | ||
| Q1 24 | — | $24.8M |
自由现金流率PBYISNFCA
| Q4 25 | 19.1% | 52.8% | ||
| Q3 25 | 17.7% | 27.9% | ||
| Q2 25 | 26.8% | -9.1% | ||
| Q1 25 | 7.7% | 11.1% | ||
| Q4 24 | 26.4% | 69.2% | ||
| Q3 24 | 13.7% | 30.2% | ||
| Q2 24 | 2.1% | -20.0% | ||
| Q1 24 | — | 30.6% |
资本支出强度PBYISNFCA
| Q4 25 | 0.0% | 2.0% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 0.0% | 3.1% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | 0.0% | 0.3% |
现金转化率PBYISNFCA
| Q4 25 | — | 3.38× | ||
| Q3 25 | 1.10× | 3.28× | ||
| Q2 25 | 2.41× | -1.18× | ||
| Q1 25 | 1.21× | 2.21× | ||
| Q4 24 | — | 22.55× | ||
| Q3 24 | 0.54× | 2.26× | ||
| Q2 24 | — | -2.33× | ||
| Q1 24 | — | 3.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
SNFCA
| Life Insurance | $29.9M | 36% |
| Mortgage | $24.8M | 30% |
| Other | $21.3M | 26% |
| Timing Of Revenue Recognition Goods Transferred At A Point In Time | $4.6M | 6% |
| Timing Of Revenue Recognition Services Transferred At A Point In Time | $2.4M | 3% |
